ALISO VIEJO, Calif.--(BUSINESS WIRE)--Clarient, Inc. (Nasdaq: CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it has extended the maturities of $19.25 million in existing credit facilities with Gemino Healthcare Finance LLC and Comerica Bank, as part of its initiative to refinance all of its credit facilities. Interest rates on Clarient’s extended Gemino and Comerica credit facilities, which are used for working capital purposes, remain unchanged.
